Dentalcorp Announces Receipt of Investment Canada Act Approval and Expected Closing Date for Acquisition by Investment Funds Affiliated with GTCR

Executive Summary

• Dentalcorp received Investment Canada Act approval for its previously announced plan of arrangement whereby GTCR‑controlled acquisition vehicle will acquire all outstanding Dentalcorp shares (except certain exempt holdings) at C$11.00 per share in cash.
• All required regulatory approvals have now been obtained; the transaction is expected to close on or about January 14, 2026, subject to customary closing conditions.
• The terms and additional details are set out in the Management Information Circular dated November 4 2025 filed on SEDAR+.

Key Details

• Transaction Structure: Plan of arrangement; GTCR‑controlled acquisition vehicle purchases all Dentalcorp subordinate voting shares and multiple voting shares (the “Shares”).
• Purchase Price: C$11.00 per Share, cash consideration.
• Exempt Shares: Shares owned by Founder/Chairman & CEO Graham Rosenberg, President & CFO Nate Tchaplia, and partner dentists who elected to roll portions of their holdings into the new vehicle remain excluded.
• Regulatory Approval: Received approval under the Investment Canada Act for the arrangement.
• Closing Timeline: Expected closing on or about January 14, 2026, pending customary conditions.
• Reference Documents: Management Information Circular dated November 4 2025 (mailed to securityholders and filed on SEDAR+).

Notable Quotes

(No direct quotes were provided in the release.)